New Delhi, March 30 Alembic Pharmaceuticals Ltd announced on Monday that it has received final approval from the US health regulator for its generic version of Paroxetine extended-release tablets, indicated for various mental health conditions.The approval from the US Food & Drug...
New Delhi, March 30 – India's pharmaceutical sector is poised to take a major step towards becoming a globally competitive powerhouse driven by innovation, according to the government, as India Pharma 2026 aims to accelerate the industry's transition from volume-based growth to value and...
biosimilars
department of pharmaceuticals
drug discovery
federation of indian chambers of commerce and industry
genericdrugs
global health
healthcare
india
india pharma 2026
innovation
pharmaceutical industry
pharmaceuticals
policy
research and development
supply chains
New Delhi, March 18 Zydus Lifesciences and Torrent Pharmaceuticals have signed a licensing and supply agreement to co-market the diabetes treatment medication Semaglutide Injection in the Indian market.Under the terms of the agreement, Zydus will manufacture and supply the product, while...
Washington, March 12 – The United States has become dangerously reliant on China for the raw materials and ingredients used in many of its most common medicines, lawmakers and expert witnesses warned at a Senate hearing, framing the issue as both a national security threat and an impending...
active pharmaceutical ingredients
arsenic
china
drug quality
genericdrugs
medicines
national security
pharmaceuticals
public health
raw materials
rosemary gibson
senate committee on aging
supply chain
ted yoho
thallium
united states
Washington, February 20 – Two top American Senators have written to the Secretary of War, Pete Hegseth, seeking details on vulnerabilities in America's pharmaceutical supply chain, warning that heavy reliance on foreign sources – particularly Communist China and India – could threaten military...
active pharmaceutical ingredients (apis)
china
department of defense
drug acquisition
fda exemptions
genericdrugs
india
national security
pharmaceutical supply chain
rare earth elements
starting materials (ksms)
tricare
united states government
united states senate
xinjiang region
New Delhi, February 13 Akums Drugs & Pharmaceuticals reported a 29.5 per cent increase in consolidated net profit to Rs 86 crore for the third quarter ended December 2025, on Friday.The company earned a net profit of Rs 66 crore in the October-December quarter of the previous fiscal year.Its...